OCT Developments Address Skin

Recent developments in optical coherence tomography (OCT) address skin cancer diagnosis. MedLumics (Madrid, Spain) has launched a three-year initiative to translate research into new clinical applications—with help from $4.9 million (€3.6 million) in Series A funding from EU joint investors. Called the BiopsyPen Project, the initiative is led by MedLumics and the Medical University of Vienna (Austria), along with European members including VTT Finland (Espoo, Finland), Delft University of Technology in The Netherlands, Exalos (Schlieren, Switzerland), the Polytechnic University of Madrid, and Optocap (Livingston, Scotland). The organizations are working to develop a handheld system for point-of-care diagnosis ...

Read Full Article

Bookmark or Share this article

Login to comment.

Michelson Diagnostics Announces Upgraded OCT Product also published in BioOptics World
CardioSpectra gets boost in OCT development from Volcano also published in BioOptics World
Laser treatment of cutaneous vascular lesions also categorized in Dermatology
In vivo reflectance-mode confocal microscopy in clinical dermatology and cosmetology also categorized in Dermatology
In vivo burn imaging using Mueller optical coherence tomography also categorized in Dermatology
Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydration in vivo. also categorized in Dermatology
Inexpensive OCT glaucoma assessment tool can track MS activity also published in BioOptics World
Application of optical coherence tomography in non-invasive characterization of skin vascular lesions also categorized in Dermatology
Machine-learning classification of non-melanoma skin cancers from image features obtained by optical coherence tomography also categorized in Dermatology
Skin treating device comprising a protected radiation exit opening also categorized in Dermatology